Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response-Reference-Cited by-同舟云学术

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Published:2018-08-20 Issue:10 Volume:24 Page:1550-1558
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Jiang Peng^ORCID,Gu Shengqing,Pan Deng,Fu Jingxin,Sahu Avinash,Hu Xihao,Li Ziyi,Traugh Nicole,Bu Xia,Li Bo,Liu Jun,Freeman Gordon J.,Brown Myles A.,Wucherpfennig Kai W.,Liu X. Shirley

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-018-0136-1.pdf

Reference63 articles.

1. Mahoney, K. M., Rennert, P. D. & Freeman, G. J. Combination cancer immunotherapy and new immunomodulatory targets. Nat. Rev. Drug Discov. 14, 561–584 (2015).

2. Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707–723 (2017).

3. Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207–211 (2015).

4. Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. New Engl. J. Med. 371, 2189–2199 (2014).

5. Nishino, M., Ramaiya, N. H., Hatabu, H. & Hodi, F. S. Monitoring immune-checkpoint blockade: response evaluation and biomarker development. Nat. Rev. Clin. Oncol. 14, 655–668 (2017).

Cited by 3199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell and Bulk Transcriptomic Analyses Reveal a Stemness and Circadian Rhythm Disturbance-related Signature Predicting Clinical Outcome and Immunotherapy Response in Hepatocellular Carcinoma;Current Gene Therapy;2025-04

2. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis;Computational and Structural Biotechnology Journal;2024-12

3. Integrating Single-cell and Bulk RNA-seq to Construct a Metastasis-related Model for Evaluating Immunotherapy and Chemotherapy in Uveal Melanoma;Current Medicinal Chemistry;2024-12

4. Uncovering the potential of APOD as a biomarker in gastric cancer: A retrospective and multi-center study;Computational and Structural Biotechnology Journal;2024-12

5. Prognostic iron-metabolism signature robustly stratifies single-cell characteristics of hepatocellular carcinoma;Computational and Structural Biotechnology Journal;2024-12